Total Payments
$800.33
2024 Payments
$388.08
Companies
9
Transactions
15
Medicare Patients
74
Medicare Billing
$7,391

Payment Breakdown by Category

Food & Beverage$800.33 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $800.33 15 100.0%

Top Paying Companies

Company Total Records Latest Year
Shionogi Inc $170.53 6 $0 (2024)
United Therapeutics Corporation $148.93 1 $0 (2024)
Teva Pharmaceuticals USA, Inc. $135.00 1 $0 (2023)
Horizon Therapeutics plc $125.00 1 $0 (2022)
ABBVIE INC. $110.39 1 $0 (2024)
AstraZeneca Pharmaceuticals LP $52.93 2 $0 (2024)
GENZYME CORPORATION $23.38 1 $0 (2022)
Electromed, Inc. $20.28 1 $0 (2024)
Merck Sharp & Dohme LLC $13.89 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $388.08 7 United Therapeutics Corporation ($148.93)
2023 $148.89 2 Teva Pharmaceuticals USA, Inc. ($135.00)
2022 $263.36 6 Horizon Therapeutics plc ($125.00)

All Payment Transactions

15 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/07/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $148.93 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
09/26/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $110.39 General
Category: NEUROSCIENCE
07/15/2024 Shionogi Inc Fetroja (Drug) Food and Beverage In-kind items and services $26.66 General
Category: Infections and Infectious Diseases
05/20/2024 Shionogi Inc Fetroja (Drug) Food and Beverage In-kind items and services $31.00 General
Category: Infections and Infectious Diseases
05/17/2024 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $20.28 General
Category: HFCWO
04/15/2024 Shionogi Inc Fetroja (Drug) Food and Beverage In-kind items and services $31.60 General
Category: Infections and Infectious Diseases
04/02/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $19.22 General
Category: Respiratory
03/15/2023 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $135.00 General
Category: Central Nervous System
01/26/2023 Merck Sharp & Dohme LLC DIFICID (Drug), RECARBRIO, ZERBAXA Food and Beverage In-kind items and services $13.89 General
Category: INFECTIOUS DISEASE
11/30/2022 Shionogi Inc Fetroja (Drug) Food and Beverage In-kind items and services $29.36 General
Category: Infections and Infectious Diseases
10/26/2022 AstraZeneca Pharmaceuticals LP TEZSPIRE (Biological) Food and Beverage In-kind items and services $33.71 General
Category: Respiratory
10/20/2022 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $23.38 General
Category: Immunology
09/21/2022 Horizon Therapeutics plc TEPEZZA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: TEPEZZA
09/05/2022 Shionogi Inc Fetroja (Drug) Food and Beverage In-kind items and services $26.61 General
Category: Infections and Infectious Diseases
07/21/2022 Shionogi Inc Fetroja (Drug) Food and Beverage In-kind items and services $25.30 General
Category: Infections and Infectious Diseases

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 74 103 $27,810 $7,391
Total Patients
74
Total Services
103
Medicare Billing
$7,391
Procedure Codes
1

All Medicare Procedures & Services

1 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 74 103 $27,810 $7,391 26.6%

About Eyal Menashe

Eyal Menashe is a Student in an Organized Health Care Education/Training Program healthcare provider based in Stony Brook, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2019. The National Provider Identifier (NPI) number assigned to this provider is 1942760467.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eyal Menashe has received a total of $800.33 in payments from pharmaceutical and medical device companies, with $388.08 received in 2024. These payments were reported across 15 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($800.33).

As a Medicare-enrolled provider, Menashe has provided services to 74 Medicare beneficiaries, totaling 103 services with total Medicare billing of $7,391. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.

Practice Information

Products in Payments

  • Fetroja (Drug) $170.53
  • TYVASO (Drug) $148.93
  • AUSTEDO (Drug) $135.00
  • TEPEZZA (Drug) $125.00
  • VRAYLAR (Drug) $110.39
  • TEZSPIRE (Biological) $33.71
  • DUPIXENT (Biological) $23.38
  • SMARTVEST (Device) $20.28
  • FASENRA (Biological) $19.22
  • DIFICID (Drug) $13.89

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Stony Brook